Research Papers

25 of 4528 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
High Antiparasitic and Antimicrobial Performance of Biosynthesized NiO Nanoparticles via Wasted Olive Leaf Extract.
Alghamdi SQ; Alotaibi NF; Al-Ghamdi SN; Alqarni LS; Amna T; Moustafa SMN; Alsohaimi IH; Alruwaili IA; Nassar AM.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Hypoxic Bone Mesenchymal Stem Cell-Derived Exosomes Direct Schwann Cells Proliferation, Migration, and Paracrine to Acc…
Wang H; Zhao H; Chen Z; Cai X; Wang X; Zhou P; Tang Y; Ying T; Zhang X; Shen Y; Wang B; Zhu W; Zhu J; Wang X; Li S.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Artesunate-Nanoliposome-TPP, a Novel Drug Delivery System That Targets the Mitochondria, Attenuates Cisplatin-Induced A…
Zhang J; Gu L; Jiang Y; Ma Y; Zhang Z; Shen S; Shen S; Peng Q; Xiao W.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Extracellular Vesicles Maintain Blood-Brain Barrier Integrity by the Suppression of Caveolin-1/CD147/VEGFR2/MMP Pathway…
Li Y; Chen J; Quan X; Chen Y; Han Y; Chen J; Yang L; Xu Y; Shen X; Wang R; Zhao Y.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Nasal Administration of bFGF-Loaded Nanoliposomes Attenuates Neuronal Injury and Cognitive Deficits in Mice with Vascul…
Zhang M; Huang SS; He WY; Cao WJ; Sun MY; Zhu NW.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Anti-Microbial Effect of AgBr-NP@CTMAB on Streptococcus Mutans and Assessment of Surface Roughness Hardness and Flexura…
Huang JJ; Jia L; Zhang QJ; Li HH; Zheng DL; Zheng M.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Critical Evaluation of Green Synthesized Silver Nanoparticles-Kaempferol for Antibacterial Activity Against Methicillin…
Hairil Anuar AH; Abd Ghafar SA; Hanafiah RM; Lim V; Mohd Pazli NFA.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Statistical optimization of hydrazone-crosslinked hyaluronic acid hydrogels for protein delivery.
Mozipo EA; Galindo AN; Khachatourian JD; Harris CG; Dorogin J; Spaulding VR; Ford MR; Singhal M; Fogg KC; Hettiaratchi MH.
J Mater Chem B (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Synthesis and Characterization of Graphene Oxide/Polyethylene Glycol/Folic Acid/Brucine Nanocomposites and Their Antica…
Ibrahim IAA; Alzahrani AR; Alanazi IM; Shahzad N; Shahid I; Falemban AH; Nur Azlina MF; Arulselvan P.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Revolutionizing Psoriasis Topical Treatment: Enhanced Efficacy Through Ceramide/Phospholipid Composite Cerosomes Co-Del…
Elhabal SF; Abdelaal N; Al-Zuhairy SAS; Mohamed Elrefai MF; Khalifa MM; Khasawneh MA; Elsaid Hamdan AM; Mohie PM; Gad RA; Kabil SL; El-Ashery MK; Jasti BR; Elzohairy NA; Elfar N; Elnawawy T; Hassan FE; El-Nabarawi MA.
Int J Nanomedicine (Unknown)
Published: 2024
2/6 Transparent
Controlled siRNA Release of Nanopolyplex for Effective Targeted Anticancer Therapy in Animal Model.
Jia J; Yang J; Qian L; Zhou B; Tang X; Liu S; Wu L; Chen J; Kuang Y.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Hybrid ultrasound and photoacoustic contrast agent designs combining metal phthalocyanines and PBCA microbubbles.
Barmin RA; Moosavifar M; Zhang R; Rütten S; Thoröe-Boveleth S; Rama E; Ojha T; Kiessling F; Lammers T; Pallares RM.
J Mater Chem B (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Dipsacus Asperoides-Derived Exosomes-Like Nanoparticles Inhibit the Progression of Osteosarcoma via Activating P38/JNK …
Lu J; Chen J; Ye J; Shi Z; Gao X; Chen P; Chang Y; Lin H; Li P.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
TiO<sub>2</sub>-Ti<sub>3</sub>C<sub>2</sub> Nanocomposites Utilize Their Photothermal Activity for Targeted Treatment o…
Wang Z; Run Z; Wang H; He X; Li J.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Donepezil-Loaded Nanocarriers for the Treatment of Alzheimer's Disease: Superior Efficacy of Extracellular Vesicles Ove…
Oliveira Silva R; Counil H; Rabanel JM; Haddad M; Zaouter C; Ben Khedher MR; Patten SA; Ramassamy C.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents.
Dong Z; Zhang X; Zhang Q; Tangthianchaichana J; Guo M; Du S; Lu Y.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Research Progress of SN38 Drug Delivery System in Cancer Treatment.
Qi QR; Tian H; Yue BS; Zhai BT; Zhao F.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Nanosuspension-Based Drug Delivery Systems for Topical Applications.
Aldeeb MME; Wilar G; Suhandi C; Elamin KM; Wathoni N.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A One Step Strategy Based on Hollow Gold Nanoparticles to Detect C-Reactive Protein with High Sensitivity (Hs-CRP) in S…
Luo C; Zhang R; Liu J; He X; Li S; Ran C; Ma S; Shen Y.
Int J Nanomedicine (Unknown)
Published: 2024
2/6 Transparent
Hydrogel Loaded with Components for Therapeutic Applications in Hypertrophic Scars and Keloids.
Zhong Y; Zhang Y; Lu B; Deng Z; Zhang Z; Wang Q; Zhang J.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Nanoplatform-Mediated Autophagy Regulation and Combined Anti-Tumor Therapy for Resistant Tumors.
Yang C; Ding Y; Mao Z; Wang W.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Engineered Exosomes Carrying miR-588 for Treatment of Triple Negative Breast Cancer Through Remodeling the Immunosuppre…
Zhang Z; Luo X; Xue X; Pang M; Wang X; Yu L; Qian J; Li X; Tian M; Lu A; Lu C; Liu Y.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Bacteria-Based Nanoprobes for Cancer Therapy.
Lu Y; Mei N; Ying Y; Wang D; Li X; Zhao Y; Zhu Y; Shen S; Yin B.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Synergistic Combination of an Intelligent Nanozyme and Radiotherapy for Treating Renal Cancer.
Lei L; Wang K.
Int J Nanomedicine (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A pH-Sensitive Nanoparticle as Reactive Oxygen Species Amplifier to Regulate Tumor Microenvironment and Potentiate Tumo…
Jiang X; Jiang X; Wu D; Xie W; Liu X; Zheng J.
Int J Nanomedicine (Unknown)
Published: 2024
2/6 Transparent